SG11202111629QA - Self-assembling protein nanocage decorated with antibodies (sapna) and parts thereof - Google Patents

Self-assembling protein nanocage decorated with antibodies (sapna) and parts thereof

Info

Publication number
SG11202111629QA
SG11202111629QA SG11202111629QA SG11202111629QA SG11202111629QA SG 11202111629Q A SG11202111629Q A SG 11202111629QA SG 11202111629Q A SG11202111629Q A SG 11202111629QA SG 11202111629Q A SG11202111629Q A SG 11202111629QA SG 11202111629Q A SG11202111629Q A SG 11202111629QA
Authority
SG
Singapore
Prior art keywords
sapna
decorated
antibodies
self
parts
Prior art date
Application number
SG11202111629QA
Inventor
Curtis D Hodge
Gregory L Hura
Todd O Yeates
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of SG11202111629QA publication Critical patent/SG11202111629QA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11202111629QA 2019-04-25 2020-04-27 Self-assembling protein nanocage decorated with antibodies (sapna) and parts thereof SG11202111629QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962838826P 2019-04-25 2019-04-25
PCT/US2020/030142 WO2020220044A2 (en) 2019-04-25 2020-04-27 Self-assembling protein nanocage decorated with antibodies (sapna) and parts thereof

Publications (1)

Publication Number Publication Date
SG11202111629QA true SG11202111629QA (en) 2021-11-29

Family

ID=72940805

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202111629QA SG11202111629QA (en) 2019-04-25 2020-04-27 Self-assembling protein nanocage decorated with antibodies (sapna) and parts thereof

Country Status (10)

Country Link
US (1) US20220196655A1 (en)
EP (1) EP3958885A4 (en)
JP (1) JP2022529512A (en)
KR (1) KR20220004115A (en)
CN (1) CN113795265A (en)
AU (1) AU2020262502A1 (en)
CA (1) CA3136730A1 (en)
IL (1) IL287221A (en)
SG (1) SG11202111629QA (en)
WO (1) WO2020220044A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11911482B2 (en) 2020-08-25 2024-02-27 The Regents Of The University Of California Self assembling protein nanoparticles as carrier molecules
CA3202378A1 (en) * 2020-11-25 2022-06-02 The Hospital For Sick Children Polypeptides targeting dr4 and/or dr5 and related compositions and methods
WO2023154731A1 (en) * 2022-02-09 2023-08-17 The Regents Of The University Of California Ligand operable protein cages

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7390489B2 (en) * 2004-10-08 2008-06-24 Komed Co., Ltd. Monoclonal antibody selectively recognizing listeria monocytogenes, hybridoma producing the antibody, test kit comprising the antibody and detection method of listeria monocytogenes using the antibody
SI23902A (en) * 2011-10-07 2013-04-30 Kemijski inštitut Self-assembling polypeptide polyhedrons
KR101477123B1 (en) * 2011-10-12 2014-12-29 한국생명공학연구원 Antibody Binding Peptide-Ferritin Fusion Protein and Use Thereof
WO2014124301A1 (en) * 2013-02-07 2014-08-14 University Of Washington Through Its Center For Commercialization Self-assembling protein nanostructures
EP3189067B1 (en) * 2014-09-04 2021-05-19 The United States of America, as represented by The Secretary, Department of Health and Human Services Recombinant hiv-1 envelope proteins and their use
CN105646717B (en) * 2016-01-26 2020-06-09 复旦大学 Long-acting HIV fusion inhibitor and application thereof
WO2018170362A2 (en) * 2017-03-16 2018-09-20 The Penn State Research Foundation Versatile display scaffolds for proteins
US20200017554A1 (en) * 2017-03-23 2020-01-16 Alpha-O Peptides Ag Self-assembling protein nanoparticles with built-in six-helix bundle proteins

Also Published As

Publication number Publication date
EP3958885A2 (en) 2022-03-02
KR20220004115A (en) 2022-01-11
IL287221A (en) 2021-12-01
WO2020220044A2 (en) 2020-10-29
CN113795265A (en) 2021-12-14
JP2022529512A (en) 2022-06-22
WO2020220044A3 (en) 2021-03-04
EP3958885A4 (en) 2023-07-19
AU2020262502A1 (en) 2021-12-02
US20220196655A1 (en) 2022-06-23
CA3136730A1 (en) 2020-10-29

Similar Documents

Publication Publication Date Title
IL287221A (en) Self-assembling protein nanocage decorated with antibodies (sapna) and parts thereof
EP3918323A4 (en) Anti-gal3 antibodies and uses thereof
EP3554544A4 (en) Anti-cub domain-containing protein 1 (cdcp1) antibodies, antibody drug conjugates, and methods of use thereof
IL289585A (en) Dll3-targeting antibodies and uses thereof
EP3962954A4 (en) Anti-galectin-9 antibodies and uses thereof
EP3802592A4 (en) Antibodies against aquaculture disease-causing agents and uses thereof
EP3962956A4 (en) Anti-hvem antibodies and use thereof
IL289656A (en) Anti-tigit antibodies and application thereof
IL291027A (en) Anti-steap1 antibodies and uses thereof
IL310938A (en) Anti-ccr8 antibodies and uses thereof
GB202017058D0 (en) Antibodies and uses thereof
IL308808A (en) Anti-ccr8 antibodies and uses thereof
IL291546A (en) Anti-kir3dl3 antibodies and uses thereof
IL291550A (en) Anti-il-27 antibodies and uses thereof
EP3753955A4 (en) Cd38 protein antibody and application thereof
EP4132974A4 (en) Anti-cd98 antibodies and uses thereof
EP4010368A4 (en) Anti-nampt antibodies and uses thereof
EP3947462A4 (en) Anti-galectin-9 antibodies and uses thereof
IL299757A (en) Sars-cov-2 proteins, anti-sars-cov-2 antibodies, and methods of using the same
IL291280A (en) Anti-cd371 antibodies and uses thereof
IL307940A (en) Anti-adgre2 antibodies and uses thereof
IL307267A (en) Anti-cd122 antibodies and uses thereof
IL286803A (en) Anti-tauc3 antibodies and uses thereof
EP4025611A4 (en) Anti-cxcr2 antibodies and uses thereof
EP3976659A4 (en) Anti-glypican-3 antibodies and uses thereof